Semi-synthetic proteins for biodegradable iron chelation
Introducing semi-synthetic proteins covalently modified with BDTA to serve as biodegradable, selective iron chelators. These proteins demonstrate strong Fe(III) affinity, offering sustainable solutions for metal chelation applications.
Overview
Semi-synthetic proteins modified with 2,2',2'',2'''-(butane-1,4-diylbis(azanetriyl))tetraacetic acid (BDTA) are designed to act as biodegradable and selective iron chelators. These proteins, derived from renewable sources like myoglobin and bovine serum albumin, exhibit strong affinity for Fe(III) while maintaining a weak affinity for Ca(II). This selective binding facilitates applications in areas requiring precise metal ion chelation, such as environmental clean-up and biomedical fields.
Technical specifications
Key features:
- Biodegradability: Semi-synthetic proteins are designed to degrade with digestive proteases, ensuring environmental safety.
- Selective Binding: Demonstrates strong affinity for Fe(III) (log K > 10) and reduced affinity for Ca(II) (log K < 5).
- Covalent Modification: Utilizes green synthesis methods to attach BDTA to proteins via amide bonds.
- Analytical Methods: Characterization through UV-vis spectroscopy, MALDI-TOF MS, and SDS-PAGE; metal affinities measured using ICP-MS.
- Proteins Used: Myoglobin and bovine serum albumin as base structures for modification.
Technology readiness level
This technology is at TRL 5, indicating that it has been validated in a relevant environment. Future steps include further validation through competition assays and biodegradation assessment using proteases, which will enhance its application potential in various industries.
About Wayne State University
Wayne State University is a comprehensive public research university anchored in Midtown Detroit, serving a large and diverse urban community with a significant health sciences footprint. Industry engagement is enabled by co-located labs in the city’s urban core, integrated clinical partnerships with regional hospital systems, and an affiliated research and technology park that houses incubators and shared facilities. Proximity to the automotive and advanced manufacturing corridor, major logistics assets, and Great Lakes infrastructure offers direct access to suppliers, regional testbeds, and deployment partners. Research is supported by competitive federal funding, including NIH and NSF, with a dedicated technology transfer office providing IP, licensing, and startup support.
delivered to your inbox.